Skip to main content
SpringerLink
Log in

The effect of oral contraceptive pill for cycle scheduling prior to GnRH-antagonist protocol on IVF cycle parameters and pregnancy outcome

  • Assisted Reproduction
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Objective

To evaluate the effect of oral contraceptive pills (OCP) pretreatment on IVF cycle outcome in GnRH-antagonist protocol.

Design

Retrospective cohort study.

Setting

Major tertiary university-affiliated center.

Patients

All patients treated with GnRH antagonist in our IVF unit during the last 3 years were included in the study. Overall 1,799 IVF cycles were performed. Of these, in 604 cycles OCP pretreatment was used prior to GnRH-antagonist for cycle scheduling. Patients were divided into two age groups—young group aged ≤35 years and older group aged ≥36 years.

Interventions

The young group underwent 927 cycles, 281 cycles with OCP pretreatment and 646 cycles without. The older group underwent 872 cycles, 323 cycles with OCP pretreatment and 549 cycles without. Data was analyzed within each age group.

Main outcome measures

Treatment duration and total dose of FSH IU used for stimulation, number of oocytes retrieved, implantation and pregnancy rates.

Results

All OCP-pretreated cycles required significantly longer stimulation than non-pretreated cycles (young: 10.76 vs. 9.21 days; older: 10.48 vs. 8.73 days, respectively) and higher total dose of FSH IU (young: 3,210 IU vs. 2,565 IU; older: 4,973 IU vs. 3,983 IU, respectively). There were no other differences in cycle characteristics between groups. Implantation and pregnancy rates were not affected by OCP pretreatment.

Conclusions

OCP pretreatment can be offered as a mode for cycle scheduling prior to GnRH-antagonist protocol, though it may be associated with longer stimulation and higher gonadotropin consumption.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Albano C, Felberbaum RE, Smitz J, Riethuller-Winzen H, Engel J, Diedrich K, et al. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group. Hum Reprod 2000;15:526–31.

    Article  PubMed  CAS  Google Scholar 

  2. Hohmann FP, Macklon NS, Fauser BC. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. J Clin Endocinol Metab 2003;88:166–73.

    Article  CAS  Google Scholar 

  3. Al-Inany H, Aboulghar M. GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod 2002;17:874–85.

    Article  PubMed  CAS  Google Scholar 

  4. Obruca A, Fischl F, Huber JC. Scheduling OPU in GnRH antagonist cycles. J Reprod Fertil 2000;4:37.

    Google Scholar 

  5. Cedrin-Durnerin I, Grange-Dujardin D, Laffy A, Parneix I, Massin N, Galey J, et al. Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study. Hum Reprod 2004;19:1979–84.

    Article  PubMed  CAS  Google Scholar 

  6. Barmat LI, Chantilis SJ, Hurst BS, Dickey RP. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization. Fertil Steril 2005;83:321–30.

    Article  PubMed  CAS  Google Scholar 

  7. Meldrum D, Scott R, Levy MJ, Alper M, Noyes N. A pilot study to assess oral contraceptive (OC) pretreatment in women undergoing controlled ovarian hyperstimulation (COH) in ganirelix acetate cycles. Fertil Steril 2002;78(3 Suppl 1):S176 Abstract P-182.

    Article  Google Scholar 

  8. Huirne JA, Van Loenen ACD, Donnez J, Pirard C, Homburg R, Schats R, et al. Effect of an oral contraceptive pill on follicular development in IVF/ICSI patients receiving a GnRH antagonist: a randomized study. Reprod Biomed Online 2006b;13(2):235–45.

    Article  PubMed  CAS  Google Scholar 

  9. Rombauts L, Healy D, Norman RJ, on the behalf of the Orgalutran Scheduling Study Group. A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients. Hum Reprod 2006;21:95–103.

    Article  PubMed  CAS  Google Scholar 

  10. Kolibianakis EM, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum Reprod 2006;21:352–7.

    Article  PubMed  CAS  Google Scholar 

  11. McCullagh P, Nelder JA. Generalised linear models. London: Chapman and Hall; 1989.

Download references

Author information

Authors and Affiliations

  1. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    Haim Pinkas, Onit Sapir, Ori M. Avrech, Avi Ben-Haroush, Jacob Ashkenzi, Benjamin Fisch & Jacob Farhi

  2. Infertility and IVF Unit, Helen Schneider Hospital for Women, Rabin Medical Center, Petach Tikva, 49100, Israel

    Haim Pinkas, Onit Sapir, Ori M. Avrech, Avi Ben-Haroush, Jacob Ashkenzi, Benjamin Fisch & Jacob Farhi

Authors
  1. Haim Pinkas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Onit Sapir
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ori M. Avrech
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Avi Ben-Haroush
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jacob Ashkenzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Benjamin Fisch
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jacob Farhi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Haim Pinkas.

Additional information

Capsule OCP prior to GnRH-antagonist protocol enables cycle scheduling without compromising cycle outcome and patient’s age is not a limitation in decision making for the use of this approach.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pinkas, H., Sapir, O., Avrech, O.M. et al. The effect of oral contraceptive pill for cycle scheduling prior to GnRH-antagonist protocol on IVF cycle parameters and pregnancy outcome. J Assist Reprod Genet 25, 29–33 (2008). https://doi.org/10.1007/s10815-007-9189-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-007-9189-7

Keywords

Search

Navigation